{"entity":{"id":"nct05678270","kind":"trial","name":"A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma","aka":[],"tldr":"A phase 2 trial of ICP-192 in biliary tract cancer, run by Beijing InnoCare Pharma Tech Co., Ltd., now recruiting.","summary":"A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma is a phase 2 interventional study registered as NCT05678270 by Beijing InnoCare Pharma Tech Co., Ltd., with 70 participants planned, started 2022-11-15 and due to reach its primary completion in 2026-05. Interventions recorded: ICP-192.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05678270","url":"https://clinicaltrials.gov/study/NCT05678270"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["cholangiocarcinoma"],"sections":[],"technologies":[],"targets":["fgfr2"],"drugs":[],"companies":["innocare"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05678270","phase":"2","setting":"A Single-Arm, Open-Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of ICP-192 in Subjects With Unresectable or Metastatic Intrahepatic Cholangiocarcinoma With FGFR2 Fusions/Rearrangements Who Have Failed Prior Therapy","sponsor":"Beijing InnoCare Pharma Tech Co., Ltd.","participation":[{"nct":"NCT05678270","source":"https://clinicaltrials.gov/study/NCT05678270","fetchedAt":"2026-10-07T16:53:49.617Z","studySha256":"2da5d3d3491c5c8b49c2a28cd0ded6f5c19f2ee96c253b63e55891c44ee329f1","overallStatus":"RECRUITING","lastUpdatePosted":"2024-02-07","leadSponsor":"Beijing InnoCare Pharma Tech Co., Ltd.","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":70,"enrolmentType":"ESTIMATED","siteCount":44,"recruitingSiteCount":5,"countries":["China"]}],"started":"2022-11-15","startedType":"actual","enrolled":70,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05678270/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"}],"target":[{"id":"fgfr2","kind":"target","name":"FGFR2","route":"/targets/fgfr2/"}],"company":[{"id":"innocare","kind":"company","name":"InnoCare Pharma","route":"/companies/innocare/"}]}}